Additionally, we observed that the treatment with PTX + CIS increased PARP-1 cleavage in SiHaP and SiHaCIS-R cells, which potentiates the apoptotic effects of these drugs, due to that these mechanisms are involved in the induction of apoptosis in human cervical cancer cells (34). Here, PARP1 is linked to in situ carcinoma.